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A B S T R A C T
Number of researches dealing with the influence of the ABO blood group antigens on the development of the oral cancer
have hypothesized that people who do not secrete these substances in the saliva are more prone to suffer from this disease.
The objective of this research is to examine this hypothesis. In total 114 subjects were examined, half of which suffered
from oral cancer, while the other half was the healthy control group. All examinees were subjected to clinical examina-
tions and the experimental group to pathohistological examination. An analysis of the secretor status was carried out us-
ing the Wiener agglutination test. The experimental group consisted of 78,95% of secretors, while the control group con-
sisted of 82,46% of secretors. This difference is not statistically significant. The starting hypothesis that non-secretors are
more prone to the development of oral cancer was not confirmed.
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Introduction
Oral cancer has a significant place in the epidemiol-
ogy of malignant diseases. Head and neck squamous cell
carcinoma was the eight leading cause of cancer death
worldwide in 20001.
The risk factors for oral cancer have been studied in
detail. Alcohol, tobacco smoking and nutritional status
are well known factors associated with the increased risk
of oral cancer. Other possible factors in the development
of oral cancer, such as Human Papillomavirus and ABO
antigens, are also being researched1,2. Existing resear-
ches link these factors with the development of cancer,
but the results are different and still only hypothesis
which have to be proven. A possible risk marker for the
susceptibility to oral cancer is patients’ secretor status.
Some people posses the ability to secrete blood group
substances in the saliva and they are referred to as »se-
cretors«, whereas others who lack such an ability are re-
ferred to as »non-secretors«. It has been demonstrated in
a number of earlier studies that the patient’s secretor
status may probably be a factor influencing the develop-
ment of systemic oral disease 3.
Immunohystochemical studies of oral squamous cell
carcinomas have shown loss of expression of A or B anti-
gens in more than 80% of cases. Studies of potentially
malignant lesion have shown loss of A/B antigen in most
lesions with epithelial dysplasia, and in the half of the le-
sions clinically classified as leukoplakia but without his-
tological evidence of epithelial dysplasia4,5.
Lamey et al. (1994) investigated the secretor status in
the saliva of a group of Sri Lankan patients and found
that secretor status does not appear to be an associated
risk marker for the development of oral cancer2. Few
years later Vidas et al. (1999) examined the influence of
the secretor status on certain precancerous lesions in
oral cavity and stated that an inability to secrete blood
group antigens in saliva could be regarded as a risk factor
in the development of oral cancer3.
The goal of this research was to examine the hypothesis
regarding the influence of secretor status on the develop-
ment of oral cancer in a selected Croatian-European pop-
ulation.
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Materials and Methods
57 patients with diagnosed oral carcinoma were ex-
amined, along with the same number of people with no
pathological changes in the mouth in the control group.
The experimental group consisted of 47 men ad 10
women. The average age of examinees was 62. The con-
trol group consisted of the same number of men and
women as the experimental group, but the average age
was 60. A biopsy and histopathological analysis has been
done on all the patients, and they have all had a pla-
nocellular carcinoma diagnosed. Stages of diseases var-
ied a lot, depending on when they had contacted their
medic. All the patients had primary tumor and none had
been previously treated for the same disease.
Data were examined with a ÷2 test.
Establishing the secretor status in the saliva3
1 ml of no stimulated saliva has been collected from
each patient, by a negative pressure suck-pump, into a
sterile glass jar, and afterwards the saliva was poured
into a sterile test-tube shut with a rubber or a plastic
cover. Test-tube was left to rest for approximately 10
minutes in a boiling water bath (to destroy enzymes). Af-
ter that, supernatant was extracted by centrifugal force
of 1700 turns through 10 minutes. Applying the Wiener
agglutination test the secretor status was analyzed. Test
serum used in this experiment, was diluted in a salted
physiological solution in proportion 1:10, the same pro-
portion that the saliva was diluted in.
The following antiserum was then placed into test-
-tubes marked I to IV:
I 1 drop of saliva + 1 drop of anti-B serum
II 1 drop of saliva + 1 drop of anti-A serum
III 1 drop of physiological solution + 1 drop of anti-B
serum
IV 1 drop of physiological solution + 1 drop of anti-A
serum
After 10 or more minutes at room temperature, 1
drop of 2–3% of suspension A erythrocytes was added
into sterile tube II and IV, and 1 drop of suspension B
erythrocytes into tube I and III. All the test tubes were
shook, and left on room temperature. After one hour the
results were ready for reading.
Test-tubes III and IV were control and agglutination
occurred in them. Agglutination in tube I is a result of
the presence of substance A2 in a saliva, i.e. of sector A,
while the agglutination in tube II is a proof of B sector.
The absence of agglutination in tubes I and II designated
AB secretor, and at the same time agglutination in tubes
I and II has proven that the person is non-secretor.
Results
Most of our examinees in, both experimental and in
control group are secretors. The secretor status of pa-
tients with oral carcinoma is shown in figure 1, and the
status of the healthy, control group, is shown in figure 2.
In the experimental group 45 examinees out of 57, or
78.95%, are secretors while 12 patients, or 21.02% do not
have blood group antigen in saliva.
47 people in the control group are secretors, or 82.46%
and 10 people are non-secretors, or 17.54%. The differ-
ence between control and experimental groups does not
have statistical significance (p>0.05).
Table 1 shows test results of the secretor status re-
garding sex. We can see that out of total of 47 men in the
experimental group, 8 (17%) are non-secretors, and 39
are secretors (83%). In the control group 40 men are se-
cretors (85.1%), and 7 are non-secretors (14.9%) Out of
10 women in the experimental group 6 of them (60%) are
secretors, and 4 women are non-secretors (40%). 7 wo-
men in the control group are secretors (70%) and 3 are
non-secretors (30%).The differences between the control
and the experimental group are not statistically signifi-
cant (p>0.05).







Fig. 1. Secretor status of 57 examinees in the experimental group






Fig. 2. Secretor status of 57 examinees in the control group which
consisted of 47 secretors (82%) and 10 non-secretors (18%).
TABLE 1
RELATION OF SECRETOR STATUS REGARDING SEX
AND AGE OF EXAMINEES
Experimental group Control group
Secretors Non-secretors Secretors Non-secretors
Men 39 8 40 7
Women 6 4 7 3
Total 45 12 47 10
Discussion
A number of studies show the relation between the
expression of A or B blood group antigens and malignant
tumors4,6–8. Experimental studies of rat colon carcinoma
cells indicate that cells with A expressions are tumoro-
genic but cannot be compared with human carcinoge-
nesis because the expression of blood group antigen is op-
posite that seen in the human4,8. Studies with human
colon carcinoma cell lines have shown that loss of expres-
sion of AB glycosyltransferase can enhance malignancy of
the cell lines4,9. Studies of bladder cancer indicate that
loss of A/B expression involves the deletion of large chro-
mosomal region including the ABO locus at 9q34 1–2,
which may contain one or more tumor suppressor ge-
nes4,7. In the normal oral cavity, keratinized epithelium
in the palate or gingiva shows little or no expression of A
or B blood group antigen. Since a change from a non-
-keratinized to a keratinized differentiation pattern is a
characteristic of many oral carcinomas and potentially
malignant lesions, the lack of expression of blood group
in such lesions could be due to a change in differentiation
pattern of the epithelium4. However, it has been demon-
strated that half of the leukoplakias that developed in
the buccal mucosa show expression of A antigen, even
tough they histologicaly appear as keratinized lesions4,5.
These findings indicate that loss of antigen is not neces-
sarily associated with hyperkeratinization or even with
oral cancer.
Lamey et al. (1991) investigated the secretor status in
saliva of a group of patients with chronic hyperplastic
candidiasis, and compared with a corresponding control
group of healthy examinees. They discovered that 68% of
those having the disease were non-secretors, whereas the
percentage of non-secretors in the control group was sta-
tistically significantly lower. Candidal leukoplakia was
considered as belonging to precancerous lesions, there-
fore, a hypothesis that the non-secretor status may have
an impact in the pathogenesis of oral cancer in non-
-secretors should be considered3,10.
The motive for this research was the article written
by a group of authors – Vidas et al. (1999), who examined
the influence of secretor status on certain precancerous
lesion in oral cavity3. What is stated in the article is the
notion that non-secretors have a more intensive disease,
with higher probability of gaining epithelial dysplasia,
what leads us to a conclusion that non-secretors might be
more prone to the development of oral carcinoma. Even
though such a research was already conducted (Lamey et
al. 1994)2, we wanted to examine the patients from the
same population (European) that was examined in the
research by Vidas et al., because the research by Lamey
et al. was conducted on the Sri Lankan population.
The results did not show a significant difference be-
tween the secretor and non-secretor status in the re-
search and the control group (17% non-secretors in the
research group and 15% in the control group). Similar re-
sults can be found in Lamey et al. research of the secretor
status in the saliva of oral carcinoma patients2.
Since the Vidas et al. experiment included mostly fe-
male population, and we could not have chosen such a
sample, because most of oral carcinoma patients are
men, we tested the relation between the secretor status
and the sex of our examinees. Even here we could not
find significant differences between the control and the
research group.
Authors of previously mentioned article tested a cou-
ple of changes that can be considered as pre-cancerous le-
sions, leukoplakia and lichen ruber planus and erosivus.
However, only a few of those changes have strong epithe-
lial dysplasia and those that do contain such a pathohis-
tological component, rarely alter into malign. Precancer-
ous lesion that has a more significant malign alteration is
erythroplakia11,12, but Vidas et al. research did not in-
clude a single examinee with such an alteration in oral
cavity. Authors state that there is significantly larger
percentage of non-secretors found in patients that have
precancerous lesion with strong epithelial dysplasia,
therefore more non-secretors can be found among pa-
tients with oral carcinoma3. The results of this study do
not confirm this hypothesis.
Conclusion
Though existing laboratory and clinic researches do
not show the correlation between ABO blood group anti-
gens and the development of oral carcinoma, this is not
clinically confirmed. A few existing clinic researches
have been conducted on a small number of examinees
and results vary a lot. Based on this brief research we can
not state that there is a correlation between the presence
of ABO antigens in the saliva and the development of
oral carcinoma. The starting hypothesis that non- secre-
tors are more prone to development of oral carcinoma is
not confirmed.
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ISPITIVANJE PRISUTNOSTI ABO(H) ANTIGENA KRVNIH GRUPA U SLINI BOLESNIKA
OBOLJELIH OD ORALNOG KARCINOMA
S A @ E T A K
U malobrojnim, do sada objavljenim istra`ivanjima o uticaju ABO antigena krvnih grupa na razvoj oralnog kar-
cinoma, postavljena je hipoteza da bi osobe koje nemaju sposobnost lu~enja tih supstanci u slini (nesekretori), mogle
biti sklonije obolijevanju od te bolesti. Cilj ovog istra`ivanja bio je ispitati navedenu hipotezu. Ukupno je ispitano 114
ispitanika, od kojih je polovica bolovala od oralnog karcinoma, dok su drugu, kontrolnu grupu sa~injavali zdravi ispi-
tanici. Svi su ispitanici klini~ki pregledani, a eksperimentalnoj grupi u~injena je patohistolo{ka dijagnoza. Ispitivanje
sekretornog statusa u~injeno je pomo}u Wienner-ovog testa aglutinacije. U eksperimentalnoj grupi bilo je 78,95% se-
kretora, dok je u kontrolnoj grupi bilo 82,46% sekretora. Ta razlika nije statisti~ki zna~ajna. Po~etna hipoteza da su
nesekretori skloniji obolijevanju od oralnog carcinoma nije potvr|ena.
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